WallStreetZenWallStreetZen

NASDAQ: ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC Stock

Buy ARCT
$16.14+0.12 (+0.75%)
Updated Jun 24, 2022
ARCT Price
$16.14
Fair Value Price
$28.26
Market Cap
$426.40M
52 Week Low
$11.70
52 Week High
$65.00
P/E
-2.14x
P/B
2.31x
P/S
45.95x
PEG
N/A
Dividend Yield
N/A
Revenue
$15.48M
Earnings
-$198.50M
Gross Margin
100%
Operating Margin
-1,268.87%
Profit Margin
-1,282.6%
Debt to Equity
0.85
Operating Cash Flow
-$141M
Beta
1.01
Next Earnings
Aug 8, 2022
Ex-Dividend
N/A
Next Dividend
N/A

ARCT Overview

Zen Score

Industry Average (30)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ARCT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ARCT ($16.14) is undervalued by 42.89% relative to our estimate of its Fair Value price of $28.26 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
ARCT ($16.14) is significantly undervalued by 42.89% relative to our estimate of its Fair Value price of $28.26 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
ARCT is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ARCT due diligence checks available for Premium users.

ARCT News

Valuation

ARCT fair value

Fair Value of ARCT stock based on Discounted Cash Flow (DCF)
Price
$16.14
Fair Value
$28.26
Undervalued by
42.89%
ARCT ($16.14) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ARCT ($16.14) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ARCT is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ARCT price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-2.14x
Industry
-2.58x
Market
20.48x

ARCT price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
2.31x
Industry
4.43x
ARCT is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ARCT's financial health

Profit margin

Revenue
$5.2M
Net Income
-$51.2M
Profit Margin
-975.8%
ARCT's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
ARCT's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$342.0M
Liabilities
$157.2M
Debt to equity
0.85
ARCT's short-term assets ($327.01M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ARCT's short-term assets ($327.01M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ARCT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$49.0M
Investing
-$2.1M
Financing
$336.0k
ARCT's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ARCT vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
ARCT$426.40M+0.75%-2.14x2.31x
COGT$426.12M-4.42%-4.21x2.27x
EWTX$422.88M+3.14%-8.45x1.62x
ABUS$422.39M-2.74%-3.89x2.55x
CNTA$432.59M-5.93%-2.12x0.90x

ARCTURUS THERAPEUTICS HOLDINGS Stock FAQ

What is ARCTURUS THERAPEUTICS HOLDINGS's quote symbol?

(NASDAQ: ARCT) ARCTURUS THERAPEUTICS HOLDINGS trades on the NASDAQ under the ticker symbol ARCT. ARCTURUS THERAPEUTICS HOLDINGS stock quotes can also be displayed as NASDAQ: ARCT.

What is the 52 week high and low for ARCTURUS THERAPEUTICS HOLDINGS (NASDAQ: ARCT)?

(NASDAQ: ARCT) ARCTURUS THERAPEUTICS HOLDINGS's 52-week high was $65.00, and its 52-week low was $11.70. It is currently -75.17% from its 52-week high and 37.95% from its 52-week low.

How much is ARCTURUS THERAPEUTICS HOLDINGS stock worth today?

(NASDAQ: ARCT) ARCTURUS THERAPEUTICS HOLDINGS currently has 26,418,965 outstanding shares. With ARCTURUS THERAPEUTICS HOLDINGS stock trading at $16.14 per share, the total value of ARCTURUS THERAPEUTICS HOLDINGS stock (market capitalization) is $426.40M.

ARCTURUS THERAPEUTICS HOLDINGS stock was originally listed at a price of $52.85 in May 22, 2013. If you had invested in ARCTURUS THERAPEUTICS HOLDINGS stock at $52.85, your return over the last 9 years would have been -69.46%, for an annualized return of -12.35% (not including any dividends or dividend reinvestments).

How much is ARCTURUS THERAPEUTICS HOLDINGS's stock price per share?

(NASDAQ: ARCT) ARCTURUS THERAPEUTICS HOLDINGS stock price per share is $16.14 today (as of Jun 24, 2022).

What is ARCTURUS THERAPEUTICS HOLDINGS's Market Cap?

(NASDAQ: ARCT) ARCTURUS THERAPEUTICS HOLDINGS's market cap is $426.40M, as of Jun 27, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

ARCTURUS THERAPEUTICS HOLDINGS's market cap is calculated by multiplying ARCT's current stock price of $16.14 by ARCT's total outstanding shares of 26,418,965.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.